Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05422430 · ClinicalTrials.gov registry record · NA
Rebreathing-induced Hypoxia and Glucose Levels
A NA study of Hypoxemia, sponsored by University of Texas at Austin.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05422430: Active NA study of Hypoxemia, sponsored by University of Texas at Austin.
NCT05422430 is a NA study of Hypoxemia that is active but no longer recruiting, run by University of Texas at Austin. The registered enrollment target is 20 participants, below the 494-participant average among 10 other Hypoxemia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05422430, a NA study of Hypoxemia, is active but no longer recruiting, sponsored by University of Texas at Austin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this research project is to determine the effect of repeated maximal voluntary apneas on glucose uptake during an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
Primary Outcome
Plasma glucose levels obtained from a venous catheter during a 2-hour oral glucose tolerance test
Conditions Studied
Interventions
- BEHAVIORAL Rebreathing-induced hypoxia
- BEHAVIORAL Spontaneous breathing
Study Locations (1)
Texas
- The Unviersity of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-21 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the registry record for NCT05422430 still lists
NCT05422430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 494-participant average among 10 other Hypoxemia trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Hypoxemia appearing as the primary indexed condition, and to 2 interventions - of which Rebreathing-induced hypoxia is the first listed.
NCT05422430 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05422430 about?
NCT05422430 is a clinical study titled "Rebreathing-induced Hypoxia and Glucose Levels". The aim of this research project is to determine the effect of repeated maximal voluntary apneas on glucose uptake during an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
What is the current status of trial NCT05422430?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-10-21. Estimated completion is 2025-04-30.
What conditions does trial NCT05422430 study?
This clinical trial studies the following conditions: Hypoxemia.
What interventions are being tested in trial NCT05422430?
The interventions under investigation include: Rebreathing-induced hypoxia (BEHAVIORAL), Spontaneous breathing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05422430?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05422430 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05422430's enrollment target sits among peer trials
20 9th of 10 higher than 2 of 10 other Hypoxemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
-
Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)
RECRUITING · NA
-
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
COMPLETED · NA
-
Pulse Oximetry With Automated Verbal Prompts
COMPLETED · NA
-
Nasotracheal Intubation With VL vs DL in Infants Trial
COMPLETED · NA
-
Postoperative Respiratory and Activity Monitoring
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI